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Abstract 
Purpose: To develop a safe mucoadhesive gel for nasal drug delivery using okra polysaccharide.  
Methods: Rizatriptan benzoate nasal gel was developed using natural polysaccharide obtained from 
the Abelmoschus esculentus. The gel formulation was characterized for pH, viscosity, mucoadhesion, 
and in vitro permeation. Permeation parameters obtained include drug flux (j), permeation coefficient 
(kP) and lag time (tL). The effect of sodium thioglycollate and sodium taurocholate on permeation of the 
gel formulations was evaluated using excised goat nasal mucosa. 
Results: Okra gel formulation showed good properties in terms of pH, viscosity and mucoadhesion. The 
drug was able to permeate through the goat nasal mucosa within 255 min. The test okra nasal gel, with 
and without enhancer, showed superior permeation properties to gels prepared with synthetic polymers 
- hydroxylpropyl methylcellulose (HPMC) and sodium carboxymethyl cellulose (NaCMC). For example, 
drug flux (j) of okra nasal gel formulation and gel formulations made with HPMC and NaCMC was 
134.8, 120.9 and 84.8, respectively.   
Conclusion: Okra mucilage is a promising natural and safe gel former that can be developed to serve 
as an alternative to currently used synthetic gel formers for nasal drug delivery.  
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Delivery of drugs for local and systemic action 
through the nasal route has been recognized as 
an important and modern way for improvement of 
bioavailability. Rapid absorption of drug through 
the thin and porous nasal epithelium and low 
enzymatic degradation makes it a better 
alternative to oral and invasive routes. Needle-
free delivery improves patient compliance with 
choice of self-medication. The drainage of 
formulation into nasopharynx through mucociliary 
clearance is the major drawback of nasal route of 
drug administration [1]. A variety of natural 
mucoadhesive gel forming plant polysaccharides 
have been identified which can minimize 
mucociliary clearance. These agents make 
intimate contact with the mucous layer, thereby 
enhancing the retention time of formulation in the 
nasal cavity and thus improve absorption and 
bioavailability [2-4]. 
 
Abelmoschus esculentus (Okra) has been 
identified as a plasma expander [5], diuretic and 
medicinal agent in dental disease [6]. Apart from 
physiological properties, the plant mucilage has 
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also been identified as a binder for tablets [7]. 
Only a limited investigation of the applicability of 
the plant polysaccharide as a gel forming agent 
has been carried out so far; hence, the present 
work was designed to evaluate the acceptability 
of okra polysaccharides as a gel-forming agent 
for the safe and effective delivery of 






Rizatriptan benzoate was received as a gift from 
Cipla, Raighar, Maharastra, India. All other 
ingredients used were of analytical grade and 
purchased from Central Drug Laboratory, New 
Delhi, India. 
 
Extraction of Okra mucilage 
 
Fresh fruits of okra (1kg) were collected from the 
cultivated plant of farm fields from Meerut in the 
month of May. Fruits were authenticated by Dr 
Anjula Pandey (Principal Scientist) of National 
Bureau of Plant Genetic Resources, New Delhi. 
A voucher specimen (no. 4762) of the fruit was 
preserved in the herbarium of Meerut Institute of 
Engineering and Technology (MIET), Meerut for 
future reference. The fruits were washed with 
distilled water and the seeds removed by making 
a longitudinal incision. The fruits were cut into 
small pieces and homogenized using a 
mechanical blender (Ikon, Sunflame, Faridabad, 
India). The resultant mucilaginous material was 
stirred in 2 L of freshly prepared and cooled 
distilled water and 500 g of ice using a 
mechanical stirrer (RQ 20 Plus, Remi, Mumbai, 
India) at 1500 rpm for 12 h. 
The mucilage was separated using a vacuum 
filter and precipitated with three times the volume 
of acetone. The precipitate was dried at 50 oC for 
2 days in hot air oven (NAAY-M40, Naugra, 
Ambala, India) and stored in a desiccator with 
calcium carbonate as desiccant until used.   
 
Preparation of nasal gel 
 
Rizatriptan benzoate (200 mg) was dissolved in 
10 ml of nasal physiological solution (0.65 % 
NaCl, 0.04 % KH2PO4, 0.09 % K2HPO4, and 0.02 
% benzalkonium chloride) at pH 6.2. The solution 
was sonicated in a bath sonicator (Lellasonic 50, 
Leela Electronics, Thane India) for 10 min until 
complete mixing of drug. The extracted okra 
mucilage (100 mg) was added to the drug 
solution to obtain a 1 % w/v dispersion. The 
resulting dispersion was stirred for complete 
hydration using a magnetic stirrer (2MLH, Remi, 
Mumbai, India) for 4 h. The resulting gel was 
sealed and stored in a refrigerator until used. 
The same method was used for the preparation 
of another batch of gel in which synthetic 
polymers - either hydroxypropyl methylcellulose 
(HPMC) or sodium carboxymethylcellulose 
(NaCMC) - were substituted for okra gel (Table 
1).   
 
Determination of gel pH 
 
The pH of the formulations containing rizatriptan 
benzoate was measured using a digital pH meter 
(pH Tutor, Eutech Instrument, Singapore). 
 
Determination of gel viscosity 
 
The viscosity of the formulations was determined 
using a Brookfield R/S Plus Rheometer (cone 
and plate model). The measuring system used 
was C – 25 Din, which is generally used for 
highly viscous liquids such as gums, mucilages 
and polymeric dispersions. Apparent viscosity 
was recorded at different rpm, ranging from 10 – 
100 at 37 °C. 
 
Table 1: Composition of gel formulations  
 













HPMC 1 100 - - - - 
HPMC 2 100 - - 0.50 - 
HPMC 3 100 - - - 0.50 
Na CMC 1 - 100 - - - 
Na CMC 2 - 100 - 0.50 - 
Na CMC 3 - 100 - - 0.50 
Okra 1 - - 100 - - 
Okra 2 - - 100 0.50 - 
Okra 3 - - 100 - 0.50 
Note: Total volume of nasal gel was 10 ml and each formulation contained 200 mg of rizatriptan benzoate 
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Evaluation of mucoadhesive strength 
 
The mucoadhesive strength of the formulations 
was evaluated using Park and Robinson method 
[9]. Excised goat nasal mucosa (2.56 cm2) was 
adhered on lower and upper probe of a modified 
balance. Nasal gel was placed between the 
mucosal layers and equilibrated at 37 0C for 15 
min. The force of adhesion (N) and bioadhesive 
strength (S) were determined from the minimum 
weight required to detach the mucosa from the 
formulation using Eqs 1 and 2.  
N = mg/1000 ……………………………….. (1) 
where m = weight required to detach the 
formulation from the nasal mucosa, and g = 
acceleration due to gravity (9.81 m/s2) 
S = N/A ………………………………………. (2) 
where A is the mucous surface area exposed to 
the formulation 
 
In vitro permeation study 
 
In vitro drug release study was performed using 
the inverted test tube method [10]. A plastic tube 
of 8 cm height and 2.54 cm2 cross-sectional area 
for permeation was selected as a donor 
chamber. Goat nasal region was procured from 
the local slaughterhouse within 1 h of slau-
ghtering the animal. Excised nasal mucosa was 
separated from the nose bone and tied carefully 
using a thread over the mouth of the tube. The 
tube was immersed in a beaker containing 100 
ml of phosphate buffer (pH 6.8), which served as 
the receptor chamber. The temperature was 
maintained 37 ± 1 oC and the solution was stirred 
continuously using a magnetic starrier. Aliquots 
(0.1 ml) were withdrawn at predetermined time 
intervals from the beaker, diluted, filtered and 
analyzed spectrophotometrically at 225 nm (UV 
1700, Shimadzu, Japan). 
 
The effect of 0.5 % w/v enhancers - sodium 
taurocholate and sodium thioglycollate - on drug 
permeation was determined.  
 
Permeability data analysis 
 
A plot of % cumulative drug permeation through 
nasal mucosa versus time was obtained. Values 
of steady state drug flux (J), permeability 
coefficient (KP) and lag time (tL) were computed 
as per Eqs 3 and 4. 
J = (dQ/dt)A ..………………………… (3) 
where dQ is the change in the quantity of drug 
(µg) permeated through nasal mucosa of surface 
area A (cm2) within time, t (min); dQ/dt was 
obtained from the slope of the straight line 
portion of plot of drug permeation versus time. 
Permeability coefficient (KP) = J/Cv ……..     (4) 
where J is the drug flux and Cv the initial 
concentration of drug in the donor compartment 
Lag time (tL) was calculated from the x-intercept 




Permeation data were expressed as mean ± 
standard deviation (SD). One way analysis of 
variance (ANOVA) was applied to determine the 
significant differences between data using 






The pH of the gels prepared using okra 
mucilage, HPMC and NaCMC was 5.99, 6.40 




The viscosity of the gels prepared from okra 
mucilage, HPMC and Na CMC was in the range 
of 5.063 to 63.106, 5.129 to 48.228 and 5.497 to 
63.164 mPas, respectively. In all cases, viscosity 
increased with decrease in rotation rate. The 
results show that the viscosity of okra based gel 
at 10 rpm, was significantly high (p < 0.001) as 
compared to that based on HPMC, but similar to 
the viscosity of that based on NaCMC (Figure 1). 
 
 
Fig 1: Viscosity of nasal gel formulations at 




The mucoadhesive strength of the drug-loaded 
nasal gels are graphically represented in Figure 
2. The results show that Okra mucilage gels 
possess nearly two times higher mucoadhesion 
than that of gel HPMC but similar strength to that 
of NaCMC gel. 
 
In vitro permeation  
 
The results indicate that nearly 100 % of 
rizatriptan benzoate permeated from the gel 
prepared using mucilage of Okra in 255 min, 
while for HPMC gel the same amount of drug 
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permeated in 270 min. For NaCMC gel, 75 % of 




Fig 2: Mucoadhesive strength of nasal gel 
formulations at various contact times 
 
Drug flux (J) of HPMC, NaCMC and Okra gels 
was 120.86 ± 0.79, 84.77 ± 1.84 and 134.77 ± 
0.66 µg/cm2 min, respectively. Similarly, the 
permeation coefficient (Kp) of the gels was (12.08 
± 0.07) x 10-3, (8.47 ± 0.18) x 10-3  and (13.47 ± 
0.07) x 10-3 cm/min, respectively (Table 2). The 
values of both parameters increased when 




Fig 3: Comparative in vitro permeation of nasal gel of 
HPMC (□), HPMC + sodium taurocholate (○), HPMC + 
sodium thioglycollate (▲), NaCMC (×), NaCMC + 
sodium taurocholate (■), NaCMC + sodium 
thioglycollate (●), okra (+), okra + sodium taurocholate 
(Δ) and Okra + sodium thioglycollate (–) 
 
Table 2: Permeation data (mean ± SD, n = 3) for 














HPMC 1 120.86±0.79 12.08±00.07 16.88±0.59 
HPMC 2 160.23±6.69 16.02±0.66 30.43±1.06 
HPMC 3 123.09±0.92 12.3±0.09 25.08±1.05 
NaCMC 1 84.78±1.84 8.47±0.18 11.50±0.67 
NaCMC 2 106.82±1.05 10.68±0.105 13.32±1.25 
NaCMC 3 99.83±6.39 9.94±0.63 12.53±0.17 
Okra 1 134.77±0.66 13.47±0.07 7.09±0.409 
Okra 2 209.58±0.13 20.95±0.013 34.66±0.053 
Okra 3 202.63±3.81 20.26±0.38 22.61±1.01 
DISCUSSION 
 
The pH of nasal gel is important because if the 
pH of the formulation is not within the range of 
nasal pH, it may cause irritation to the nasal 
mucosa/tissue on application [11]. Since the 
normal pH of nasal cavity varies from 5.5 to 6.5, 
all the nasal gels evaluated would be non-
irritable to the nasal mucosa. The gel prepared 
from okra exhibited viscosity which was similar to 
those prepared with synthetic polymers indicating 
that the natural mucilage is suitable for nasal gel 
formulations.  
 
Similarly, the mucoadhesive strength of the okra 
nasal gel was comparable to that of the synthetic 
polymers tested. Viscosity and mucoadhesive 
strength of the formulation affect the retention 
ability of the nasal cavity. Mucoadhesive strength 
increased proportionately with increasing contact 
time of the gel. This may be because by 
increasing contact time, more free chains of the 
mucoadhesive polymer becomes available which 
penetrate into the mucosa and exhibit higher rate 
of adhesion. Natural gels would be preferable to 
synthetic polymers since they would likely be 
safer. 
 
Permeation data indicates that virtually 100 % 
drug permeation was achieved with okra gel in 
255 min without any permeation enhancer and 
that it was superior in this regard to the gels 
formulated with synthetic polymers. Drug 
permeation from nasal gel containing NaCMC as 
geling agent was least, which may be due to the 
inverse relation between drug release and 
viscosity. For drug molecules to permeate across 
the nasal epithelia they must first diffuse out of 
the formulation. Normally, drug release from 
hydrogel is governed by the diffusion. The 
apparent viscosity and polymeric chain 
complexity of the formulation influence diffusion 
of molecules [12].   
 
Permeation of rizatriptan benzoate through nasal 
epithilia was clearly influenced by the types of 
gelling agent and permeation enhancer used. 
Okra nasal gel was influenced more by 
permeation enhancer (sodium taurocholate and 
sodium thioglychollate) than the synthetic gels 
tested. The reason may be that okra gel ensures 
easy availability of the enhancers for action on 
epithelial membrane by facilitating rapid release 
from the gel matrix, whereas synthetic polymers 
effect sustained release of enhancers in the 
same manner in the same way they do to drugs. 
Overall, okra mucilage seems a better alternative 
to the synthetic polymers for safe delivery of drug 
via nasal route.  
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Both enhancers used in the present study are 
bile salts, and have been extensively employed 
to enhance drug permeation through epithilia. 
They are believed to act on both transcellular 
and paracellular pathways to enhance drug 
permeation. Their physiological role is related to 
solubilization and micellar entrapment of 
intracellular lipid which cause lipid emulsification 
and thus ensure easy passage of drug 
molecules. In addition, bile salts promote 
membrane fluidity and extraction of cellular 




The present study indicates that Abelmoschus 
esculentus mucilage gel is a potentially 
mucoadhesive material for delivery of drug via 
the nasal route. The data obtained demonstrate 
that this natural polymeric material possess good 
mucoadhesion and permeation chracteristics. Its 
biodegradable nature as well as likely low 
toxicity (since plant fruit is widely consumed as 
food) further supports its use as a suitable 
alternative to synthetic mucoadhesive polymers 
for nasal delivery. Further investigation, however, 
is required for complete elucidation of its safety 
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